A01K 2207/35
Animals modified by environmental factors
Official title: Animals modified by environmental factors, e.g. temperature, O2
A01K2207/35 (Animals modified by environmental factors) appears on 22 US grants and 61 published applications in this corpus.
Search patents in A01K- Granted patents
- 22
- Published applications
- 61
- Assignees
- 49
- Inventors
- 149
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 3 |
| 2016 | 0 | 4 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 5 |
| 2020 | 3 | 5 |
| 2021 | 4 | 8 |
| 2022 | 1 | 7 |
| 2023 | 5 | 6 |
| 2024 | 4 | 4 |
| 2025 | 1 | 2 |
| 2026 | 2 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for the expression of constitutively active RAP1A from a VMD2 promoter25 Aug 2026US 12,714,757 B2University of Flordia Research Foundation, Inc.
- Aquacultured crustacean and method of producing same2 Jun 2026US 12,642,287 B2Nippon Suisan Kaisha, Ltd.
- Treatment of MST1 related diseases and disorders27 May 2025US 12,312,586 B2Empirico Inc.
- Light generating system for arthropod keeping24 Dec 2024US 12,171,204 B2Signify Holding B. V.
- Production of fertile XY female animals by silencing of genes on the Y chromosome23 Jul 2024US 12,041,918 B2Regeneron Pharmaceuticals, Inc.
- Aquacultured crustacean and method of producing same17 Sep 2026US 2026/0271976 A1Nippon Suisan Kaisha, Ltd.
- Utilization of a hibernation-like state in neurological diseases27 Aug 2026US 2026/0248961 A1Okinawa Institute of Science and Technology School Corporation
- Polypeptide and use thereof2 Jul 2026US 2026/0183408 A1Shenzhen Chenyang Biological Technology Co., Ltd
- Apomorphine for treating or improving post-traumatic stress disorder11 Jun 2026US 2026/0158023 A1Postech Research and Business Development Foundation
- Cholinergic gene therapy to preserve hearing16 Apr 2026US 2026/0102514 A1The Johns Hopkins University
Most cited
By later US patents
- Methods for cancer treatment2US 10,549,082 B2The Board of Trustees of the Leland Stanford Junior University · 2020
- Method for producing recombinant proteins in insects2US 11,991,994 B2Future Fields Cellular Agriculture and Research LTD. · 2024
- Production of fertile XY female animals by silencing of genes on the Y chromosome1US 10,893,666 B2Regeneron Pharmaceuticals, Inc. · 2021
- Expression of neuropeptides1US 11,376,337 B2California Institute of Technology · 2022
- Inhibition of angiogenesis1US 9,179,654 B2Cornell Research Foundation, Inc. · 2015